Abstract
A novel class C β-lactamase (FOX-8) was isolated from a clinical strain of Escherichia coli. The FOX-8 enzyme possessed a unique substitution (Phe313Leu) compared to FOX-3. Isogenic E. coli strains carrying FOX-8 showed an 8-fold reduction in resistance to ceftazidime relative to FOX-3. In a kinetic analysis, FOX-8 displayed a 33-fold reduction in kcat/Km for ceftazidime compared to FOX-3. In the FOX family of β-lactamases, the Phe313 residue located in the R2 loop affects ceftazidime hydrolysis and alters the phenotype of E. coli strains carrying this variant. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
Original language | English |
---|---|
Pages (from-to) | 5158-5161 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 57 |
Issue number | 10 |
DOIs | |
Publication status | Published - 1 Oct 2013 |